How effective is oral candesartan in the treatment of ischemic stroke?

Updated: May 27, 2020
  • Author: Edward C Jauch, MD, MS, FAHA, FACEP; Chief Editor: Helmi L Lutsep, MD  more...
  • Print

A study in 339 patients with ischemic stroke found that oral candesartan reduced combined vascular events but had no effect on disability. [102] However, the Scandinavian Candesartan Acute Stroke Trial (SCAST), a randomized, placebo-controlled, double-blind study involving 2029 patients, found no indication of benefit from candesartan but did find some suggestion of harm. [104]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!